When the Policy Makers Who Are Supposed to Protect Us, Get Risk Wrong. Weighing the pros and cons of risk- vs. hazard-based approaches to risk management: do we err on the side of caution, or should we be certain that something poses a real risk before we restrict its use?
Efsa launches transparency initiative. Hans Muilerman from PAN Europe has some reservations, based on his experiences as a member of the authority’s stakeholder forum. “The problem with Efsa is that they decide what our needs on transparency are,” he said.
BPA: contested science, divergent safety evaluations. It’s time to ‘dare to start again’ with bisphenol A (BPA) risk assessment as industry-sponsored research and peer-reviewed studies seem to “deviate strongly”, according to the European Environment Agency (EEA).
Project launched to drive change in review process for chemicals. [This is us!] Review techniques used in evidence-based medicine should be transferred to chemical risk assessment to help resolve differences and controversies. This is the message from a new initiative, the Policy from Science Project, looking to engage a broad range of stakeholders, including industry, to challenge current thinking on reform of chemicals risk assessment, in particular the way that chemical reviews are conducted.